Barros, Thaís de Sousa 
; Brumano, Larissa Pereira ; Freitas, Marcela; Pessoa Junior, Adalberto ; Parachin, Nádia; Magalhães, Pérola de Oliveira
Fonte: Pharmaceutics. Unidade: FCF
Assuntos: ESCHERICHIA COLI, ENZIMAS, REATORES BIOQUÍMICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROS, Thaís de Sousa et al. Development of processes for recombinant L-Asparaginase II production by Escherichia coli Bl21 (De3): from shaker to bioreactors. Pharmaceutics, v. 13, p. 1-15 art. 14, 2021Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics13010014. Acesso em: 08 jul. 2024.APA
Barros, T. de S., Brumano, L. P., Freitas, M., Pessoa Junior, A., Parachin, N., & Magalhães, P. de O. (2021). Development of processes for recombinant L-Asparaginase II production by Escherichia coli Bl21 (De3): from shaker to bioreactors. Pharmaceutics, 13, 1-15 art. 14. doi:10.3390/pharmaceutics13010014NLM
Barros T de S, Brumano LP, Freitas M, Pessoa Junior A, Parachin N, Magalhães P de O. Development of processes for recombinant L-Asparaginase II production by Escherichia coli Bl21 (De3): from shaker to bioreactors [Internet]. Pharmaceutics. 2021 ; 13 1-15 art. 14.[citado 2024 jul. 08 ] Available from: https://doi.org/10.3390/pharmaceutics13010014Vancouver
Barros T de S, Brumano LP, Freitas M, Pessoa Junior A, Parachin N, Magalhães P de O. Development of processes for recombinant L-Asparaginase II production by Escherichia coli Bl21 (De3): from shaker to bioreactors [Internet]. Pharmaceutics. 2021 ; 13 1-15 art. 14.[citado 2024 jul. 08 ] Available from: https://doi.org/10.3390/pharmaceutics13010014
